Homocysteine and disease: Causal associations or epiphenomenons?

Area of Science:

• Biochemistry
• Nutritional Science
• Pathology

Background:

• Nutritional and genetic deficiencies in folate and vitamin B12 elevate cellular homocysteine (Hcy), leading to increased plasma Hcy levels.
• The precise role of elevated plasma Hcy in disease pathogenesis remains a significant area of scientific debate.
• While folic acid reduces neural tube defects, its efficacy in mitigating cardiovascular disease and cognitive impairment via Hcy reduction is controversial.

Purpose of the Study:

• To investigate the molecular mechanisms and cellular interactions of homocysteine (Hcy) in disease.
• To clarify whether elevated plasma Hcy is a causal factor, mediator, or merely a marker of pathological conditions.
• To address the discrepancies between epidemiological, intervention, and basic research findings concerning Hcy.

Main Methods:

• Review of existing literature on homocysteine metabolism and its association with various diseases.
• Analysis of the relationship between cellular Hcy status and plasma Hcy levels.
• Examination of the impact of Hcy-lowering interventions, such as folic acid supplementation.

Main Results:

• Plasma Hcy levels do not consistently reflect intracellular Hcy status, contributing to research inconsistencies.
• The molecular mechanisms linking Hcy to cellular processes and disease development are not fully elucidated.
• The therapeutic benefits of Hcy-lowering interventions for cardiovascular and cognitive health require further validation.

Conclusions:

• Understanding the precise role of plasma Hcy in pathogenesis is crucial for improving diagnostic and therapeutic strategies.
• Further research is essential to determine if Hcy is a mechanistic player or an epiphenomenon in disease.
• Clarifying the Hcy-plasma level disconnect is key to reconciling diverse research findings and advancing clinical practice.